| Menopausal syndrome

Climara Pro vs Estrogel

Side-by-side clinical, coverage, and cost comparison for menopausal syndrome.

Deep comparison between: Climara Pro vs Estrogel with Prescriber.AI

AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.

Safety signalsEstrogel has a higher rate of injection site reactions vs Climara Pro based on FDA-approved prescribing information

Coverage gaps3 major payers require step therapy for Estrogel but not Climara Pro, including UnitedHealthcare

Category

Climara Pro

Estrogel

At A Glance

RouteTransdermal patch

FrequencyWeekly

ClassEstrogen/progestogen combination

RouteTopical

FrequencyDaily

ClassEstrogen

Indications

Menopausal syndrome
Osteoporosis, Postmenopausal

Menopausal syndrome
Postmenopausal atrophic vaginitis

Dosing

Menopausal syndrome, Osteoporosis, Postmenopausal 0.045 mg estradiol/0.015 mg levonorgestrel per day applied transdermally once weekly; for vasomotor symptoms, attempts to discontinue should be made at 3 to 6 month intervals.

Menopausal syndrome, Postmenopausal atrophic vaginitis EstroGel 0.06% 1.25 g (0.75 mg estradiol) once daily applied as a thin layer over the entire arm on the inside and outside from wrist to shoulder.

Contraindications

Undiagnosed abnormal genital bleeding
Breast cancer or history of breast cancer
Estrogen-dependent neoplasia
Active DVT, PE, or a history of these conditions
Active arterial thromboembolic disease (e.g., stroke or MI), or a history of these conditions
Known anaphylactic reaction, angioedema, or hypersensitivity to Climara Pro
Hepatic impairment or disease
Protein C, protein S, or antithrombin deficiency, or other thrombophilic disorders

Abnormal genital bleeding of unknown etiology
Current or history of breast cancer
Current or history of estrogen-dependent neoplasia
Active DVT, PE, or history of these conditions
Active arterial thromboembolic disease (e.g., stroke or MI), or history of these conditions
Known anaphylactic reaction, angioedema, or hypersensitivity to EstroGel or any excipient
Hepatic impairment or disease
Protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders

Drug Interactions

1699View drug interactions

1224View drug interactions

Adverse Reactions

Most common (>3%) Application site reaction, vaginal bleeding, breast pain, upper respiratory infection, back pain, depression, headache, pain, flu syndrome, abdominal pain, arthralgia, edema, flatulence, hypertension, bronchitis, sinusitis, urinary tract infection

Serious Cardiovascular disorders, malignant neoplasms

Postmarketing Changes in bleeding patterns, abdominal distension, abdominal pain, nausea, alopecia, night sweats, pruritus, rash, hot flush, dizziness, headache, insomnia, application site reaction, weight increased, anaphylactic reaction

Most common (>=5%) Breast pain, headache, flatulence

Serious Cardiovascular disorders, malignant neoplasms

Postmarketing Endometrial cancer, breast cancer, deep vein thrombosis, myocardial ischemia, phlebitis, nausea, alopecia, rash, retinal vein occlusion, meningioma, angioedema, hepatitis

Pharmacology

Estrogen/progestogen combination; estradiol binds nuclear estrogen receptors in estrogen-responsive tissues to reduce elevated postmenopausal gonadotropin levels, while levonorgestrel inhibits gonadotropin production and counteracts the proliferative effects of estrogen on the endometrium.

Estradiol is the principal intracellular human estrogen, acting through binding to nuclear receptors in estrogen-responsive tissues; it modulates pituitary gonadotropin secretion via a negative feedback mechanism to reduce elevated LH and FSH levels seen in postmenopausal women.

View Full FDA Information

View full FDA information

Enter your patient's insuranceCheck specific coverage details for your patient.

Most Common Insurance

Anthem BCBS

Climara Pro